Titanium Zirconium (TiZr) Mini Implants

Sponsor
University of Bern (Other)
Overall Status
Recruiting
CT.gov ID
NCT03837158
Collaborator
(none)
72
2
2
39
36
0.9

Study Details

Study Description

Brief Summary

H0: "Within the first year post-placement, four interforaminally placed, immediately loaded 2.4 mm narrow-diameter one-piece TiZr implants with miniaturized stud-type attachments show improved patient-reported outcome measures (PROMS) compared to two interforaminally placed, early loaded, TiZr two-piece implants with stud-type attachments to retain a mandibular overdenture."The specific aim is to compare both treatment alternatives to evaluate which one may be recommended for elderly edentulous patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: early loading
  • Procedure: immediate loading
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Is the Stabilization of a Mandibular Overdenture Employing Four Novel One-piece Immediately Loaded TiZr Implants With Miniaturized Stud-type Attachments a Feasible Alternative to Two Two-piece Early Loaded Tissue-level Implants With Regular Stud-type Attachments?
Actual Study Start Date :
Sep 1, 2019
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Control-group

Two Tissue Level TiZr Sand blasted long grit acid-etched (SLA) implants placed in positions 33 and 43 (diameter 3.3mm, length ≥10mm), early loading

Procedure: early loading
two TiZr implants on SLA surface

Experimental: Experimental-group

Four narrow-diameter implants (NDI) TiZr SLA implants in positions 34, 32, 42, and 44 (diameter 2.4mm, length ≥10mm), immediate loading

Procedure: immediate loading
four TiZr implants on SLA surface

Outcome Measures

Primary Outcome Measures

  1. Geriatric Oral Health Assessment Index (GOHAI) [One-year follow-up]

    Change from baseline questionnaires in Oral Health Related Quality of Life (OHRQoL). Scores 0-60: higher values represent lower OHRQoL

Secondary Outcome Measures

  1. Additional Oral Health Impact Profile for edentulism (OHIP-EDENT) [Follow-up (up to 365 days)]

    Change from baseline questionnaires

  2. Additional PROM Denture Satisfaction Index (DSI) [Baseline, follow-up (up to 365 days)]

    Change in Denture Satisfaction higher values represent better satisfaction (0-1200mm)

  3. Implant Survival [at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up]

    Survival (yes/no)

  4. Implant Success [at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up]

    Success according to Misch (2007) Misch criteria scores 1-4: higher values represent better success

  5. Prosthetic Survival [Baseline, follow-up (up to 365 days)]

    Prosthetic Survival (yes/no): is the denture still in place?

  6. Chewing Efficiency [Baseline, follow-up (up to 365 days)]

    Color mixing test

  7. Plaque Index [at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up]

    Plaque Index Scores 0-3 3= thick plaque is visible along gingival margin 2= plaque is visible along gingival margin, with or without air drying 1= following air drying, plaque is not visible but can be wiped off with an explorer 0= following air drying, plaque is not visible nor can be wiped off with an explorer

  8. Bleeding Index [at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up]

    Bleeding Index Scores 0-3 0= Healthy gingival Gingival look inflamed, but don't bleed when probed Gingival look inflamed and bleed when probed Ulceration and spontaneous bleeding

  9. Pocket Probing depth [at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up]

    depth measured in mm

  10. Time-Cost-Analysis [After surgery, after implants loading, after follow-up (up to 365 days)]

    Total treatment time will be collected and added. Total treatment cost will be evaluated and a ratio will be calculated. The groups will be compared on the base of this ration

  11. Cost Effectiveness and Willingness to Pay [Total change and time at 1y follow-up]

    Cost effectiveness wil be calculated as a ratio of treatment cost in relation to change of GOHAI sum score. This will allow to evaluate how much monetary item is needed to achieve a change in GOHAI

  12. In-vivo evaluated loss of retentive force [after implant loading (expected to be after 6 weeks on average) and at follow-up (up to 365 days)]

    Measurement with a hand-held digital force gauge

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • At patient level:

  • Written informed consent

  • Age ≥ 18 years

  • Sufficient complete dentures (Marxkors and Ferger, 1989) not older than 1 year

  • Patient is unsatisfied with mandibular denture to the degree that he/she seeks treatment

  • At site level:

  • Healed edentulous mandible (minimum 8 weeks since last extraction)

  • Minimal ridge dimensions 5.5 mm (width) by 12 mm (height) in the anterior (interforaminal) area, allowing the placement of 3.3 (endosseous diameter) by 10 mm (length) implants

  • Opposing dentition: complete denture on a edentulous maxilla

  • Physical status (PS) 1 and 2 (American Society of Anesthesiologists)

Exclusion Criteria:
  • At patient level

  • Any physical or mental disorder that would interfere with the ability to perform adequate oral hygiene or the capability of providing written informed consent and compliance to the protocol

  • Any disorder that would interfere with wound healing or represent a contraindication for oral surgery such as, but not limited to, uncontrolled diabetes or conditions resulting in or requiring immunosuppression, radiation, chemotherapy, frequent use of antibiotics or antiresorptive medication such as bisphosphonates

  • Pregnancy or lactation

  • Heavy smoking habit with > 20 cig/d

  • Severe bruxism or clenching habits, present oro-facial pain

  • At site level:

  • Ridge defects requiring staged bone augmentation procedures (simultaneous Guided Bone Regeneration (GBR) within the ridge contour allowed)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Private Practice Langenthal Bern Switzerland 4900
2 University of Bern Bern Switzerland 3010

Sponsors and Collaborators

  • University of Bern

Investigators

  • Principal Investigator: Beat Wallkamm, Dr, Private Practice
  • Study Director: Martin Schimmel, Prof, University of Bern

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Bern
ClinicalTrials.gov Identifier:
NCT03837158
Other Study ID Numbers:
  • Mini 1286_2018
First Posted:
Feb 12, 2019
Last Update Posted:
Jun 1, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 1, 2022